Rock Springs Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-165,000
Closed -$11.4M 161
2021
Q2
$11.4M Hold
165,000
0.22% 105
2021
Q1
$12.7M Hold
165,000
0.28% 96
2020
Q4
$16.3M Sell
165,000
-10,000
-6% -$1.22M 0.35% 90
2020
Q3
$24.8M Hold
175,000
0.63% 54
2020
Q2
$34.5M Hold
175,000
0.95% 44
2020
Q1
$34.3M Hold
175,000
1.42% 23
2019
Q4
$36.2M Hold
175,000
1.14% 26
2019
Q3
$26.7M Buy
175,000
+10,000
+6% +$1.64M 1.06% 28
2019
Q2
$21.3M Hold
165,000
0.77% 49
2019
Q1
$19.4M Sell
165,000
-12,500
-7% -$1.26M 0.75% 48
2018
Q4
$16.3M Hold
177,500
0.77% 39
2018
Q3
$20M Sell
177,500
-7,500
-4% -$792K 0.72% 47
2018
Q2
$17.1M Hold
185,000
0.66% 52
2018
Q1
$18.5M Hold
185,000
0.79% 47
2017
Q4
$17.3M Sell
185,000
-29,000
-14% -$2.74M 0.79% 41
2017
Q3
$21.8M Sell
214,000
-7,500
-3% -$655K 1% 30
2017
Q2
$16.9M Buy
221,500
+11,500
+5% +$967K 0.86% 42
2017
Q1
$18.1M Hold
210,000
1.04% 31
2016
Q4
$13.5M Hold
210,000
0.9% 36
2016
Q3
$13.6M Hold
210,000
0.85% 37
2016
Q2
$11.6M Hold
210,000
0.86% 38
2016
Q1
$8.78M Hold
210,000
0.74% 42
2015
Q4
$13.2M Hold
210,000
1% 31
2015
Q3
$8.55M Buy
210,000
+57,500
+38% +$3.31M 0.69% 51
2015
Q2
$7.85M Buy
+152,500
New +$8.09M 0.57% 64

Other funds holding LKFT

Rock Springs Capital Management's LKFT Position: Q3 2021 in Review

Rock Springs Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2021, closing a stake of 165,000 shares — an estimated $11.4M sold.

Rock Springs Capital Management first reported a position in LKFT in Q2 2015 and held it in 25 quarters. The position peaked at $36.2M in Q4 2019. 81 funds tracked by Wall St. Rank hold LKFT as of Q3 2021.

  • Rock Springs Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Rock Springs Capital Management sold 165,000 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2021, an estimated $11.4M.
  • Rock Springs Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 25 quarters.
  • Rock Springs Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $36.2M in Q4 2019.
  • 81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2021.

Based on Rock Springs Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.